Mucor Circinelloides F. Lusitanicus
Generic Name: mucor circinelloides f. lusitanicus
Brand Names:
Mucor Circinelloides F. Lusitanicus
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: MUCOR CIRCINELLOIDES F. LUSITANICUS (.001 g/mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: MUCOR CIRCINELLOIDES F. LUSITANICUS (.001 g/mL). Category: BLA.
Dosage
Available as solution for intradermal, percutaneous, subcutaneous use.
Related Medications
Iva Axillaris
iva axillaris
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: IVA AXILLARIS POLLEN (.05 g/mL). Category: BLA.
As-3
as-3
ADDITIVE SOLUTION FORMULA 3 (AS-3), 300 mL Each 100 mL contains: Citric Acid (Monohydrate), USP 0.042 g Monobasic Sodium Phosphate (Monohydrate), USP 0.276 g Sodium Chloride, USP 0.410 g Adenine, USP 0.030 g Dextrose (Anhydrous), USP 1.000 g Sodium Citrate (Dihydrate), USP 0.588 g containing 15 mEq of Sodium. . Description
Rituximab
rituximab
CD20-directed Cytolytic Antibody [EPC]
11 DESCRIPTION Rituximab is a genetically engineered chimeric murine/human monoclonal IgG 1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium that may contain the antibiotic gentamicin. Gentamicin is not detectable in the final product.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.